Cargando…

CD markers polymorphisms as prognostic biomarkers in hematological malignancies

The clusters of differentiation (CD) are surface molecules used for immunophenotyping of cells. The expression of CD markers is widely used to classify hematological malignancies, including leukemia and lymphoma. Single nucleotide polymorphisms (SNPs) are crucial genetic changes that can be associat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shahrabi, Saeid, Ghanavat, Majid, Behzad, Masumeh Maleki, Purrahman, Daryush, Saki, Najmaldin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications, Pavia, Italy 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385526/ https://www.ncbi.nlm.nih.gov/pubmed/32782727 http://dx.doi.org/10.4081/oncol.2020.466

Ejemplares similares

Prognostic significance of aberrant CD5 expression in B-cell leukemia
por: Jaseb, Kaveh, et al.
Publicado: (2019)

Thrombocytopenia in solid tumors: Prognostic significance
por: Ghanavat, Majid, et al.
Publicado: (2019)

Expression of CD markers in JAK2(V617F) positive myeloproliferative neoplasms: Prognostic significance
por: Shahrabi, Saeid, et al.
Publicado: (2018)

The Expression of Microvesicles in Leukemia: Prognostic Approaches
por: Ehsanpour, Ali, et al.
Publicado: (2019)

Epigenetic and metabolic reprogramming in inflammatory bowel diseases: diagnostic and prognostic biomarkers in colorectal cancer
por: Deris Zayeri, Zeinab, et al.
Publicado: (2023)

Bone Marrow Blood Vessels: Normal and Neoplastic Niche
por: Shahrabi, Saeid, et al.
Publicado: (2016)

Genetics and Epigenetics of Myelodysplastic Syndromes and Response to Drug Therapy: New Insights
por: Shahrabi, Saeid, et al.
Publicado: (2016)

Evaluation of immunophenotypic markers and clinico-hematological profile in chronic lymphocytic leukemia: implications for prognosis
por: Bagheri, Marziye, et al.
Publicado: (2020)

MicroRNA Modulation during the In vitro Culture of Hematopoietic Stem Cells Prior to Transplantation
por: Shahrabi, Saeid, et al.
Publicado: (2017)

Molecular Regulation of Bone Marrow Metastasis in Prostate and Breast Cancer
por: Rahim, Fakher, et al.
Publicado: (2014)

Vitamin D and its receptor polymorphisms: New possible prognostic biomarkers in leukemias
por: Pezeshki, Seyed Mohammad Sadegh, et al.
Publicado: (2018)

BRAF Mutation in Hairy Cell Leukemia
por: Ahmadzadeh, Ahmad, et al.
Publicado: (2014)

New Clues to Prognostic Biomarkers of Four Hematological Malignancies
por: Salifu, Samson Pandam, et al.
Publicado: (2022)

Application of Bayesian Decision Tree in Hematology Research: Differential Diagnosis of β-Thalassemia Trait from Iron Deficiency Anemia
por: Jahangiri, Mina, et al.
Publicado: (2021)

Neoplastic Bone Marrow Niche: Hematopoietic and Mesenchymal Stem Cells
por: Saki, Najmaldin, et al.
Publicado: (2011)

Involvement of MicroRNA in T-Cell Differentiation and Malignancy
por: Saki, Najmaldin, et al.
Publicado: (2015)

The IFN-Ɣ + 874 A/T polymorphism is associated with malignant breast cancer in a population from the southwest of Iran
por: Rezaeean, Hadi, et al.
Publicado: (2021)

The effects of preoperative supplementation with a combination of beta‐hydroxy‐beta‐methylbutyrate, arginine, and glutamine on inflammatory and hematological markers of patients with heart surgery: a randomized controlled trial
por: Norouzi, Mona, et al.
Publicado: (2022)

CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies
por: Testa, Ugo, et al.
Publicado: (2014)

Role of CD47 in Hematological Malignancies
por: Eladl, Entsar, et al.
Publicado: (2020)

Progranulin (PGRN) as a regulator of inflammation and a critical factor in the immunopathogenesis of cardiovascular diseases
por: Saeedi-Boroujeni, Ali, et al.
Publicado: (2023)

Platelets in In-stent Restenosis: From Fundamental Role to Possible Prognostic Application
por: Haybar, Habib, et al.
Publicado: (2020)

The impact of Mir-9 regulation in normal and malignant hematopoiesis
por: Khosravi, Abbas, et al.
Publicado: (2018)

Polymorphism of alpha-1-antitrypsin in hematological malignancies
por: Topic, Aleksandra, et al.
Publicado: (2009)

Bloodstream Infections in Febrile Hematologic Oncology Patients in a Referral Hospital in Ahvaz, Iran: A Descriptive Cross-Sectional Study
por: Jaseb, Kaveh, et al.
Publicado: (2022)

Regulatory T Cells and Their Prognostic Relevance in Hematologic Malignancies
por: D'Arena, Giovanni, et al.
Publicado: (2017)

Soluble CD14 as a Diagnostic and Prognostic Biomarker in Hematological Patients with Febrile Neutropenia
por: Korpelainen, Sini, et al.
Publicado: (2017)

MicroRNA-binding site polymorphisms in hematological malignancies
por: Dzikiewicz-Krawczyk, Agnieszka
Publicado: (2014)

BMI1: A Biomarker of Hematologic Malignancies
por: Sahasrabuddhe, Anagh A.
Publicado: (2016)

Matrix Metalloproteinases Polymorphisms as Prognostic Biomarkers in Malignant Pleural Mesothelioma
por: Štrbac, Danijela, et al.
Publicado: (2017)

Association of Chromosomal Translocation and MiRNA Expression with The Pathogenesis of Multiple Myeloma
por: Saki, Najmaldin, et al.
Publicado: (2014)

MicroRNA-Based Linkage between Aging and Cancer: from Epigenetics View Point
por: Saeidimehr, Saeid, et al.
Publicado: (2016)

Prognostic significance of mutated genes in megakaryocytic disorders
por: Asnafi, Ali Amin, et al.
Publicado: (2019)

Targeting CD22 for B-cell hematologic malignancies
por: Xu, Jia, et al.
Publicado: (2023)

The role of CD180 in hematological malignancies and inflammatory disorders
por: Edwards, Kurtis, et al.
Publicado: (2023)

Prognostic significance of isochromosome 17q in hematologic malignancies
por: Koczkodaj, Dorota, et al.
Publicado: (2021)

Outcomes and Prognostic Factors in Critical Patients with Hematologic Malignancies
por: Chen, Chieh-Lung, et al.
Publicado: (2023)

The ectonucleotidases CD39 and CD73 on T cells: The new pillar of hematological malignancy
por: Jiang, Xuan, et al.
Publicado: (2023)

Does DNA Methylation Plays a Critical Role in Osteoblastic Differentiation of Mesenchymal Stem Cells (MSCs)?
por: Saki, Najmaldin, et al.
Publicado: (2013)

CT-128 Simple Prognostic Markers in Patients With Hematological Malignancies and COVID-19 Infection: Single-Center Experience
por: Rakha, Nahed Moawad, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_btle1hpa1ifrr6b0t3248fupu4